341
Views
8
CrossRef citations to date
0
Altmetric
Review

Immune Regulation of the cGAS-STING Signaling Pathway in the Tumor Microenvironment and Its Clinical Application

ORCID Icon, , , &
Pages 1501-1516 | Published online: 01 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ruben Serrano, Marcus Lettau, Michal Zarobkiewicz, Daniela Wesch, Christian Peters & Dieter Kabelitz. (2022) Stimulatory and inhibitory activity of STING ligands on tumor-reactive human gamma/delta T cells. OncoImmunology 11:1.
Read now

Articles from other publishers (7)

Lindsey Carlsen, Shengliang Zhang, Xiaobing Tian, Arielle De La Cruz, Andrew George, Taylor E. Arnoff & Wafik S. El-Deiry. (2023) The role of p53 in anti-tumor immunity and response to immunotherapy. Frontiers in Molecular Biosciences 10.
Crossref
Jelena Viculin, Marina Degoricija, Katarina Vilović, Ivana Gabela, Lucija Franković, Eduard Vrdoljak & Jelena Korac-Prlic. (2023) Elevated Tumor Cell-Intrinsic STING Expression in Advanced Laryngeal Cancer. Cancers 15:13, pages 3510.
Crossref
Dongquan Xiang, Xinli Han, Jianxiong Li, Jiabing Zhang, Haihua Xiao, Ting Li, Xuelin Zhao, Hejian Xiong, Meng Xu & Wenzhi Bi. (2023) Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcoma. Materials Today Bio 20, pages 100675.
Crossref
Noor Shakfa, Deyang Li, Sarah Nersesian, Juliette Wilson-Sanchez & Madhuri Koti. (2022) The STING pathway: Therapeutic vulnerabilities in ovarian cancer. British Journal of Cancer 127:4, pages 603-611.
Crossref
Shilin Zhi, Bin Yang, Shengning Zhou, Jianan Tan, Guangyu Zhong & Fanghai Han. (2022) Immune-Related LncRNAs to Construct a Prognosis Risk-Assessment Model for Gastric Cancer. Current Oncology 29:7, pages 4923-4935.
Crossref
Carlos Wagner S. Wanderley, Tatiana Strava Correa, Mariana Scaranti, Fernando Queiroz Cunha & Romualdo Barroso-Sousa. (2022) Targeting PARP1 to Enhance Anticancer Checkpoint Immunotherapy Response: Rationale and Clinical Implications. Frontiers in Immunology 13.
Crossref
Laxmi Kumari, Yashwant Kumar & Alka Bhatia. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 20 .